查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542923

全球骨骼生長促效劑市場 - 2024-2031

Global Bone Growth Stimulators Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球骨骼生長促效劑市場在2023年達到16.4億美元，預計到2031年將達到244萬美元，在2024-2031年預測期間複合年成長率為5.1%。

骨骼生長促效劑可以改善接受骨融合手術的患者的身體骨癒合過程。這些刺激器可以穿戴在室外或在植入治療期間使用，例如心臟再同步治療 (CRT) 和植入式心律轉復除顫器 (ICD)。它可以透過施加電波或超音波來治癒骨折。這種非侵入性骨癒合治療方法是骨移植的替代方法。

該市場的成長是由於對微創治療的日益偏好、骨折和脊柱損傷病例的增加、老年人口的增加以及隨之而來的骨科疾病和損傷病例的增加以及運動損傷發生率的增加而推動的。

此外，全球醫院和手術中心數量的不斷增加、血小板和富血漿（PRP）在其他應用中的利用率不斷增加以及新興經濟體為該市場的成長提供了機會。

市場動態：

司機

對非侵入性和微創手術治療的需求不斷成長

全球骨生長促效劑市場的需求是由多種因素所驅動的。關鍵因素之一是，患者擴大選擇非侵入性和微創手術治療，因為它們比傳統手術有好處，例如併發症更少、住院時間更短、疼痛減輕、感染風險更低和恢復更快。

此外，該行業的主要參與者推出了創新平台和技術，以推動該市場的成長。例如，2023 年 5 月，專門從事脊椎和骨科解決方案的知名公司 Orthofix Medical Inc. 宣布，其 STIM onTrack 行動應用程式榮獲 MedTech Breakthrough 頒發的「最佳患者參與行動應用程式」獎。

此外，2023 年 4 月，脊椎和骨科領域的知名公司 Orthofix Medical 推出了兩款專為微創脊椎 (MIS) 手術量身定做的通路牽開器系統。 Lattus 側入路系統和 Fathom 椎弓根牽開器系統的推出升級了該公司的入路解決方案組合。

限制

產品召回、高昂的治療和診斷成本、嚴格的核准程序、有限的醫療報銷政策、基於 BMP 的治療的副作用以及人們的認知有限等因素預計將阻礙市場。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 對非侵入性和微創手術治療的需求不斷成長
      • 醫療保健技術進步
      • 老年人口增加
      • 骨骼和關節疾病的負擔不斷增加
      • 運動和事故相關的骨科損傷數量不斷增加
    • 限制
      • 產品召回
      • 治療和診斷費用高
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求
  • PESTEL分析
  • 專利分析
  • SWOT分析

第 6 章：COVID-19 分析

第 7 章：依產品

  • 植入骨生長刺激器
  • 超音波骨生長刺激器
  • 外部骨骼生長刺激器（組合磁場 (CMF) 設備）
  • 脈衝電磁場 (PEMF) 設備
  • 電容耦合 (CC) 裝置）
  • 非侵入性骨生長刺激器
  • 侵入性骨生長促效劑
  • 其他

第 8 章：按申請

  • 脊椎融合手術
  • 外傷和骨折
  • 成骨
  • 口腔顎面外科
  • 延遲癒合和骨不連骨折
  • 其他

第 9 章：最終用戶

  • 骨科診所
  • 醫院
  • 門診手術中心
  • 學術及研究機構
  • 居家護理
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Zimmer Biomet
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Orthofix Medical Inc
  • Enovis Corporation
  • ZimVie Inc
  • OssaTechnics
  • Kinex Medical Company, LLC
  • VQ OrthoCare
  • SIG Orthopaedic
  • Elizur
  • IGEA SpA (LIST NOT EXHAUSTIVE)

第 13 章：附錄

簡介目錄
Product Code: MD1278

Market Overview

The Global Bone Growth Stimulators Market reached US$ 1.64 billion in 2023 and is expected to reach US$ 2.44 million by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.

Bone growth stimulators improve the body's bone healing process in patients undergoing bone fusion surgery. These stimulators can be worn outside or used during implantation therapies such as cardiac resynchronization therapy(CRT), & implantable cardioverter defibrillators (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is an alternative to bone grafts.

The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic disease and injuries, and growing incidences of sports injuries.

In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet and rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.

Market Dynamics: Drivers

Growing Demand for the Non-Invasive and Minimally Invasive Surgeries Treatments

The demand for the global bone growth stimulators market is driven by multiple factors. One of the key factors is that patients are increasingly opting for non-invasive and minimally invasive surgical treatments due to their benefits over traditional procedures, such as fewer complications, shorter hospitalization, reduced pain, lower risk of infections, and faster recovery.

Moreover, major players in the industry introduced innovative platforms and technologies that would propel this market growth. For instance, in May 2023, Orthofix Medical Inc., a prominent company specializing in spine and orthopedic solutions, declared that its STIM onTrack mobile app received an award for the "Best Patient Engagement Mobile App" from MedTech Breakthrough.

Also, in April 2023, Orthofix Medical, an eminent company in the spine and orthopedics sector, introduced two access retractor systems tailored for minimally invasive spine (MIS) procedures. The launch of the Lattus lateral access system and the Fathom pedicle-based retractor system upgrades the company's portfolio of access solutions.

Restraints

Factors such as product recalls, high cost of treatment and diagnosis, stringent approval process, limited medical reimbursement policies, adverse effects of BMP-based therapy, and limited awareness among people are expected to hamper the market.

Segment Analysis

The global bone growth stimulators market is segmented based on product, application, end-user, and region.

The spinal fusion surgeries segment accounted for approximately 55.8% of the global bone growth stimulators market share

The spinal fusion surgeries segment is expected to hold the largest market share over the forecast period. An electrical bone growth stimulator is a supplemental form of therapy for spinal fusion surgery. It may be used as an adjunct to spinal fusion surgery to help enhance the chances of achieving a successful bone fusion.

Furthermore, major key players in the industry introduce people awareness publications and device approvals help to drive this market growth. For instance, in December 2023, Orthofix Medical Inc. announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion procedures in patients at risk for pseudarthrosis.

For the same source, the SpinalStim device is the only bone growth stimulation therapy system that is FDA-approved as both an adjunct treatment for lumbar spinal fusion and as a nonsurgical treatment for spinal pseudarthrosis.

Similarly, in April 2024, the Xstim received premarket approval from the US Food and Drug Administration (FDA) for its Xstim spine fusion stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.

Geographical Analysis

North America accounted for approximately 42.4% of the global bone growth stimulators market share

North America region is expected to hold the largest market share over the forecast period. The growing incidence of orthopedic conditions, such as osteoporosis, osteoarthritis, and sports-related injuries, is expanding the target patient population for bone growth stimulators in this region.

Osteoarthritis is regarded as one of the most common articular diseases among people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, with that number expected to rise to 78 million by 2040.

In this region, major key player's presence and product approvals propel this market growth. For instance, in May 2022, Orthofix Medical Inc. (US) obtained FDA premarket approval for the AccelStim bone growth stimulation device.

This approval signifies that the device has met the necessary regulatory requirements and can now be marketed and sold in the United States. The AccelStim bone growth stimulation device is expected to offer advanced therapeutic options for promoting bone healing and treating fractures effectively.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global bone growth stimulators market. The pandemic caused a sudden drop in elective surgeries, which is a significant contributor to the demand for bone growth stimulators.

Many orthopedic clinics were temporarily shut down or operated at reduced capacity, further reducing the demand for bone growth stimulators. The pandemic drastically promoted the disease burden and bundled the healthcare systems with a high influx of coronavirus-infected patients, thereby hampering other medical services, including bone growth stimulation treatments.

Market Segmentation

By Product

Implanted Bone Growth Stimulators

Ultrasonic Bone Growth Stimulators

External Bone Growth Stimulators (Combined Magnetic Field (CMF) Devices

Pulsed Electromagnetic Field (PEMF) Devices

Capacitive Coupling (CC) Devices)

Non-Invasive Bone Growth Stimulators

Invasive Bone Growth Stimulators

Others

By Application

Spinal Fusion Surgeries

Trauma Injury and Fractures

Osteogenesis

Oral and Maxillofacial Surgeries

Delayed Union & Nonunion Bone Fractures

Others

By End-Users

Orthopedic Clinics

Hospitals

Ambulatory Surgical Centers

Academic & Research Institutes

Home Care

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., Enovis Corporation, ZimVie Inc., OssaTechnics, Kinex Medical Company, LLC, VQ OrthoCare, SIG Orthopaedic, Elizur, and IGEA S.p.A. among others.

Key Developments

In November 2023, Simulare Medical announced the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its growing line of cleft surgery simulators.

In November 2022, DJO, LLC proclaimed the achievement of the bone growth stimulation device industry from OrthoLogic Corporation.

In August 2022, Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ActaStim-S Spine Fusion bone growth stimulator system.

Why Purchase the Report?

To visualize the global bone growth stimulators market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global bone growth stimulators market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global bone growth stimulators market report would provide approximately 62 tables, 63 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for the Non-Invasive and Minimally Invasive Surgeries Treatments
      • 4.1.1.2. Technological Advancements in Healthcare
      • 4.1.1.3. Rising Geriatric population
      • 4.1.1.4. Rising Burden of Bone and Joint Disorders
      • 4.1.1.5. Rising Number of Sports and Accident-Related Orthopedic Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recalls
      • 4.1.2.2. High Cost of the Treatment & Diagnosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Implanted Bone Growth Stimulators*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ultrasonic Bone Growth Stimulators
  • 7.4. External Bone Growth Stimulators (Combined Magnetic Field (CMF) Devices
  • 7.5. Pulsed Electromagnetic Field (PEMF) Devices
  • 7.6. Capacitive Coupling (CC) Devices)
  • 7.7. Non-Invasive Bone Growth Stimulators
  • 7.8. Invasive Bone Growth Stimulators
  • 7.9. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Spinal Fusion Surgeries*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Trauma Injury and Fractures
  • 8.4. Osteogenesis
  • 8.5. Oral and Maxillofacial Surgeries
  • 8.6. Delayed Union & Nonunion Bone Fractures
  • 8.7. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Orthopedic Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Academic & Research Institutes
  • 9.6. Home Care
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. South Korea
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Zimmer Biomet *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio & Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Orthofix Medical Inc
  • 12.3. Enovis Corporation
  • 12.4. ZimVie Inc
  • 12.5. OssaTechnics
  • 12.6. Kinex Medical Company, LLC
  • 12.7. VQ OrthoCare
  • 12.8. SIG Orthopaedic
  • 12.9. Elizur
  • 12.10. IGEA S.p.A. (LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us